• News
    • Press Releases
  • Media Kit
  • Media Resources
    • Images
    • Video
  • Media Contacts
  • Corporate Site

Impulse Dynamics®’ INTEGRA-D Trial Completes Efficacy Phase

by Impulse Dynamics | Apr 28, 2025 | Press Releases

First phase of enrollment of single device for CCM® and ICD therapy complete MARLTON, N.J., April 28, 2025 (GLOBE NEWSWIRE) — Impulse Dynamics® plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to...

Impulse Dynamics Receives European CE Mark For Expanded Indication For Diastolic Heart Failure

by Impulse Dynamics | Mar 28, 2025 | Press Releases

CCM therapy is now indicated for symptomatic heart failure patients with diastolic or systolic ventricular dysfunction, offering a broader range of patients a new option for improving quality of life and reducing heart failure hospitalization MARLTON, N.J., March 28,...

Impulse Dynamics Expands Executive Leadership Team

by Impulse Dynamics | Sep 24, 2024 | Press Releases

Extensive depth of experience comes with new leaders – Chief Operating Officer, Chief Financial Officer, Chief Administrative Officer and Chief Science and Strategy Officer MARLTON, N.J., September 24, 2024 (GLOBE NEWSWIRE) — Impulse Dynamics plc, a global medical...

Impulse Dynamics Surpasses 10,000 Patients Benefiting from CCM® Therapy for Heart Failure

by Impulse Dynamics | May 13, 2024 | Press Releases

Milestone Highlights Transformative Symptom Management for Patients Living with Heart Failure MARLTON, N.J., May 13, 2024 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), announced...

Impulse Dynamics Completes $136M Financing Round

by Impulse Dynamics | Feb 14, 2024 | Press Releases

Continued Progress Earns Financing to AccelerateCommercial Growth and Advancing Pipeline MARLTON, N.J., February 14, 2024 (GLOBE NEWSWIRE) — Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), is...

Impulse Dynamics Receives Full-Body MRI-Conditional Approval for Optimizer Smart Mini System

by Impulse Dynamics | Oct 30, 2023 | Press Releases

Reflecting Company Commitment to Innovation in Support of Patient Need MARLTON, N.J., October 30, 2023 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), announced today it has...
« Older Entries

Clinical Trial Corporate Investors

  • Follow
  • Follow
  • Follow
  • Follow

We welcome the opportunity to hear from you in these social channels, but remember we work in a highly-regulated industry with unique legal considerations. Before engaging, please read and adhere to our established community guidelines for each channel.

The information posted on this site was factually accurate on the date of publication.

© Impulse Dynamics 2024   Privacy Policy